Senate Orders FTC To Probe PBM-Made Biosimilars, Slams FDA Over Orange Book Mismanagement
The Letters Were Sent To The Two Agencies On 30 September
The US FTC and FDA both received letters from the Senate but with different messaging. One commends for achieved findings and requests a new investigation and another scalds for not doing the assigned job.
